McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Merck Announces the Launch of the Merck Digital Sciences Studio to Help Healthcare Startups Quickly Bring their Innovations to Market

by McKesson Ventures | Jun 29, 2022 | Media Coverage, Press Releases

Merck, known as MSD outside the U.S. and Canada, has announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development. MDSS will support early-stage biomedical startups with direct...

McKesson Ventures Takes the ParityPledge to Commit to Increasing Representation for Women and People of Color

by McKesson Ventures | Jun 17, 2022 | Press Releases

McKesson Ventures has signed the Parity.org ParityPledge® in Support of People of Color and in Support of Women. The ParityPledge simply asks that companies commit to interview and consider at least one qualified woman and person of color for every open role, VP and...

Koneksa Raises $45M Series C Financing to Accelerate Expansion of Digital Biomarker Platform

by McKesson Ventures | Feb 7, 2022 | Press Releases

Digital biomarker design and validation company Koneksa recently announced that it had completed a Series C funding round in which it raised $45 million. The funding round was led by AyurMaya, with Velosity Capital and Takeda Ventures participating as well. Existing...

Reimagine Care Secures $25 Million in Series A Funding to Drive Commercialization of Home-Centered, Value-Based Cancer Care

by McKesson Ventures | Jan 25, 2022 | Press Releases

Technology-enabled service provider Reimagine Care is a leader in promoting support for oncologists by delivering valuable, home-centered cancer care. It recently announced that a $25 million capital raise has been completed. Led by LRVHealth, Santé Ventures, and...

Announcing our latest investment led by Spectrum Equity and McKesson Ventures

by McKesson Ventures | Jan 19, 2022 | Media Coverage, Portfolio News

RxVantage recently shared news of its latest investment directed by McKesson Ventures and Spectrum Equity. These two investors will be joining RxVantage’s existing investors, which include Merck Global Health Innovation Fund, Slater Technology Fund, Javelin Venture...
Page 2 of 8«12345...»Last »

Recent Posts

  • Samsung Electronics Acquires Xealth, Bridging The Gap Between Wellness and Medical Care
  • CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth
  • Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry
  • Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada
  • Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care
McKesson Ventures
One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us

Cookie Settings

In the News

Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care

Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials

Lynx Closes $27 Million Oversubscribed Series A, Aims to Revolutionize Healthcare Payments and Administration

HarmonyCares Announces 2023 Results for its High Needs REACH ACO

©2025 McKesson Ventures | Privacy Notice | Disclaimer
  • Follow
  • Follow